Pulmonary Disease Clinical Trial
Official title:
Fully Automated Scan Technique Optimisation of Scan Timing in Chest CT
Computed Tomography Angiography (CTA) is a non-invasive imaging tool widely used for various
indications. Contrast media (CM) is used to enhance the intravascular lumen and organ
parenchyma, depending on the indication. Recent technical advances in CT scan techniques
allow for a very fast scan acquisition with substantially increased image quality in terms of
temporal and spatial resolution. However, with faster scan acquisition, challenges arise with
regard to CM bolus timing. The risk of outrunning the CM bolus in these fast acquisitions is
higher, resulting in a decreased intravascular attenuation and subsequent hypothetical
increase in non-diagnostic image quality.
Previous studies have investigated the reduction of CM volume. When reducing the CM volume,
the total injection time decreases and the window of peak enhancement shortens and becomes
more narrow. The latter increases when injecting small CM volumes with higher flow rates.
Although the peak enhancement increases, the window of peak enhancement decreases more
rapidly. Thus, when administered with the same flow rate, the peak of the enhancement curve
will be lower, narrower and faster compared to larger CM volumes. This, in combination with
the faster scan acquisition makes the timing of the start of the scan highly important, since
scanning at the peak enhancement is necessary to achieve a diagnostic image quality.
New bolus tracking auto-delay software (Fully Automated Scan Technique, FAST, Siemens
Healthineers) automatically estimates the delay needed to scan at the peak of the enhancement
curve. With help of this software, the optimal individual scan delay and enhancement can be
achieved, and the risk of non-diagnostic scans should decrease. Therefore, this study aims to
evaluate the performance of the Bolus Tracking Auto-Delay (FAST) software in patients
receiving a standard chest CT with regard to the number of non-diagnostic scans (< 300 HU)
and compare this with standard care (manual set pre-scan delay).
Computed Tomography Angiography (CTA) is a non-invasive imaging tool widely used for various
indications. Contrast media (CM) is used to enhance the intravascular lumen and organ
parenchyma, depending on the indication. Recent technical advances in CT scan techniques
allow for a very fast scan acquisition with substantially increased image quality in terms of
temporal and spatial resolution. These faster scan times account for a significant reduction
in radiation dose, which is desirable in light of the "As Low As Reasonably Achievable"
(ALARA) principle. Another advantage of the newer 'high-end' scanners is the use of lower
tube voltages and lower CM volumes, since many studies have shown that CM volumes can be
reduced with usage of lower tube voltages.
However, with faster scan acquisition, challenges arise with regard to CM bolus timing. The
risk of outrunning the CM bolus in these fast acquisitions is higher, subsequently leading to
a decreased or even non-diagnostic enhancement (in Hounsfield Units (HU)). In addition,
decreased CM volumes due to usage of lower tube voltages also add to the risk of outrunning
the bolus. When reducing the CM bolus, the injection time decreases and the window of peak
enhancement is shorter and more narrow. Also, when injecting these smaller CM volumes at
higher flow rates, although the peak enhancement is increased, the window of peak enhancement
decreases more rapidly. Thus, when administered with the same flow rate, the peak of the
enhancement curve will be lower, narrower and faster compared to larger CM volumes. This, in
combination with the faster scan acquisition makes the timing of the start of the scan (scan
start delay) highly important, since scanning at the peak enhancement is necessary to achieve
a diagnostic image quality.
To determine scan delay, two techniques frequently used in daily clinical routine are the
'test bolus' and 'bolus tracking' technique. With the first, a smaller CM bolus is
administered before the actual scan, and the time to peak of the intravascular enhancement is
determined with help of dedicated software (DynEva, Siemens Healthineers, Forchheim,
Germany). When using the 'bolus tracking' technique, no additional CM volume is administered.
A region of interest (ROI) is placed in a large artery of interest (e.g. ascending or
descending aorta), and a threshold enhancement is set prior to the scan (e.g. 100 HU).
Repetitive low dose scans are acquired at the same level and the arrival of the CM bolus is
followed. Once the threshold is reached, the scanner automatically starts the scan. Between
reaching the threshold and the actual start of the scan, a manual post-tracking delay is set
prior to scanning. This delay is necessary for both the table movement of the scanner to the
start of the scan and the breath hold command. The problem is that this manual post-tracking
delay is set prior to the scan, without information of the patient's cardiovascular dynamics
(e.g. cardiac output). Since cardiac output can vary greatly inter- and intra-patient, this
fixed post-tracking delay may not be appropriate for all patients. Scanning with a
sub-optimal post tracking delay could potentially result in suboptimal arterial enhancement
and insufficient diagnostic quality.
With new bolus tracking auto-delay software (Fully Automated Scan Technique, FAST, Siemens
Healthineers) the incidence of scans made at a suboptimal attenuation could be reduced. This
software is similar to the 'bolus tracking' technique, the difference is that the manual
post-tracking delay is calculated automatically by the software. During the low-dose
repetitive scans at the level of the ROI, the attenuation in the ROI is used to predict the
optimal enhancement curve. The software takes the injection protocol, tube voltage and
patient parameters into account. A previously acquired database of numerous enhancement
curves is consulted to predict a best fitted enhancement curve of the individual patient. The
software then calculates the optimal post-tracking scan delay to scan at the peak
enhancement. Thus, the optimal individual scan delay and enhancement based on the patients
physiology can be achieved, and the risk of non-diagnostic scans should decrease. Therefore,
this study aims to evaluate the performance of the FAST software in patients receiving
standard chest CT with regard to the number of non-diagnostic scans (< 300 HU) and compare
this with standard care (manual set pre-scan delay).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Active, not recruiting |
NCT02504697 -
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
|
||
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Terminated |
NCT00524095 -
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
|
Phase 2 | |
Completed |
NCT00210249 -
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
|
||
Completed |
NCT00023114 -
p450 Mediated Lung Toxicity
|
N/A | |
Recruiting |
NCT06056882 -
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
|
||
Completed |
NCT03994848 -
Incentive Spirometry Prehabilitation Study
|
N/A | |
Completed |
NCT00366509 -
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
|
||
Withdrawn |
NCT05100160 -
Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
|
Phase 3 | |
Completed |
NCT03229473 -
Fall Risk Assessment in COPD
|
||
Recruiting |
NCT04767074 -
A Non-pharmacological Cough Control Therapy
|
N/A | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT04996693 -
On Dose Efficiency of Modern CT-scanners in Chest Scans
|
N/A | |
Recruiting |
NCT04996173 -
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
|
N/A | |
Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Recruiting |
NCT02862418 -
Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)
|